-
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
03 Nov 2025 12:00 GMT
… durability. Standard-of-care docetaxel monotherapy in patients with … About Non-Small Cell Lung Cancer
Lung cancer is the most commonly … ,4 Approximately 85% of lung cancer cases are NSCLC, with … our non-small cell lung cancer clinical trials) and our …
-
Driven by Strong Demand, ImmunityBio Reports 467% Year-to-Date Unit Growth and $75 Million in Sales Year-to-Date, Up 434% from Q3 2024
05 Nov 2025 06:25 GMT
… GBM patients. Non-Small Cell Lung Cancer (NSCLC): ImmunityBio has initiated enrollment … with TEVIMBRA ® (BeOne) and docetaxel versus docetaxel alone in patients with checkpoint … lymphopenia in non-small cell lung cancer," said Dr. Patrick Soon …
-
The Value of Dynamic of Alkaline Phosphatase and Neutrophil-to-Lymphocyte Ratio in Predicting the Efficacy of Neoadjuvant Immunochemotherapy in Patients with Non-Small Cell Lung Cancer
25 Oct 2025 08:42 GMT
… docetaxel in patients with previously treated non-small-cell lung cancer … cell lung cancer patients treated with nivolumab. Lung Cancer. … -Small-Cell Lung Cancer Undergoing Neoadjuvant Immunochemotherapy … Assessment of Lung Cancer Resection Specimens …
-
Prospects and Challenges of Chitosan-Based Drug Carriers for Anticancer Agents’ Delivery Against Lung Cancer: A Review
24 Oct 2025 14:10 GMT
… lung cancer into non-small cell lung cancer (NSCLC) and small cell lung cancer … lung cancer.
Current treatment modalities for lung cancer … -NPs inhibited lung tumor growth by … docetaxel and curcumin ameliorates anti-tumor chemoimmunotherapy in lung cancer …
-
Revolution Medicines to Present Updated Elironrasib Safety and Efficacy Data in Patients with KRAS G12C Non-Small Cell Lung Cancer Following Treatment with a KRAS(OFF) G12C Inhibitor
22 Oct 2025 16:12 GMT
… 80%-85% of all lung cancers, and most patients have … Daraxonrasib (RMC-6236) vs. Docetaxel in RAS-Mutant NSCLC”
… Cancer Institute. Non-Small Cell Lung Cancer Treatment. Available at: https … Society. Key Statistics for Lung Cancer. Available at: https:…
-
<![CDATA[Emerging Biomarkers Open New Frontiers in Lung Cancer Therapy]]>
19 Oct 2025 18:00 GMT
… biomarkers in lung cancer.
Biomarkers in Lung Cancer
Lung cancer is the … for lung cancer and selecting patients for lung cancer therapy,” … 15% to 16% of lung cancers, representing a promising … versus docetaxel in previously treated non-small cell lung cancer. …
-
<![CDATA[Dr Perol on Unmet Need for Post Immunotherapy Strategies in Lung Cancer]]>
16 Oct 2025 19:50 GMT
… , which is still docetaxel or docetaxel plus anti-angiogenic drugs … in non–small cell lung cancer (NSCLC).
This topic … Bridging the Gaps in Lung Cancer consensus meeting.
Perol noted … based regimens remains either docetaxel or docetaxel combined with anti- …
-
‘In EGFR-mutated lung cancer treatment, combo therapy emerges as new standard’
14 Oct 2025 07:23 GMT
… 2025 Asia Conference on Lung Cancer (ACLC25), held in … Treatment for EGFR-mutated lung cancer is evolving beyond the … in treating EGFR-mutated lung cancer,” Professor Ahn stated. … antibody-drug conjugates (ADCs), docetaxel ± ramucirumab combination therapy, …
-
<![CDATA[China’s Center for Drug Evaluation Grants Breakthrough Therapy Designation to Ivonescimab in TNBC]]>
04 Nov 2025 18:51 GMT
… or metastatic non–small cell lung cancer (NSCLC) resistant to EGFR TKI … NSCLC; and in combination with docetaxel for those with locally advanced …
-
Candel Therapeutics Showcases Immunotherapy Leadership at SITC 2025, Demonstrating Integration of Clinical Innovation, Multi-Omics, and Artificial Intelligence to Advance Next-Generation Immunotherapies in Solid Tumors
04 Nov 2025 14:00 GMT
… lung cancer … Lung Cancer, 2025. [2] Ahn, M.J., et al., Datopotamab Deruxtecan Versus Docetaxel … for Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer … Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer …
About
© 1995-2025